drugset / Trial / NCT01232543
Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis
NaSingle-groupOpen-labelTreatment
Summary
The aim of the trial is to assess Adrenal Suppression potential when pediatric subjects are administered Product 0405 for the treatment of Atopic Dermatitis
Timeline
- Start
- 2010-11
- Primary completion
- 2011-08
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Product 0405 | Unknown | — | Topical |